ĀÜĄņĀŅĀ×

Adrian (Ad) Rawcliffe has served as our Chief Executive Officer since September 2019 and is a member of our Executive Team. Previously, he served as our Chief Financial Officer from March 2015 through September 2019.

Mr. Rawcliffe has over 20 years of experience within the biopharmaceutical industry and most recently served as Senior Vice President, Finance of GSKā€™s North American Pharmaceuticals business. He joined GSK in 1998 and his other senior roles at the company included Senior Vice President Worldwide Business Development and R&D Finance, where he was responsible for all business development and finance activities for GSKā€™s Pharmaceuticals R&D business and Managing Partner and President of SR One Ltd, GSKā€™s ventureā€‘capital business. Mr. Rawcliffe currently serves as a nonā€‘executive director of WAVE Life Sciences (NASDAQ: WVE).